Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Suriname Tech News.
Press releases published on August 4, 2025
Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 4, 2025
$96.0 million in 2Q VYJUVEK revenue and $525.4 million since launch in 3Q 2023 VYJUVEK approved in Japan for the treatment of DEB patients from birth Strong balance sheet, ending the quarter with $820.8 million in cash and investments PITTSBURGH, Aug. 04, …
Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025
GlobeNewswire
·
August 4, 2025
WATERTOWN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report second quarter …
Descartes Acquires Finale Inventory
GlobeNewswire
·
August 4, 2025
Broadens Multi-Channel Inventory Management Capabilities to Scale Across Ecommerce Operations of all Sizes WATERLOO, Ontario and ATLANTA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting …
BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 4, 2025
—Q2 2025 ORLADEYO net revenue of $156.8 million (+45 percent y-o-y)— —Q2 2025 operating profit of $29.8 million (+239 percent y-o-y); non-GAAP operating profit of $57.0 million (+160 percent y-o-y)— —Company makes additional $50 million paydown of term …
SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates
GlobeNewswire
·
August 4, 2025
SALT LAKE CITY, Utah, Aug. 04, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in silicon nitride (Si₃N₄) for musculoskeletal applications, today announced the …
Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
GlobeNewswire
·
August 4, 2025
WARREN, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
Accumulus Synergy Spins Out Accumulus Technologies to Scale Proven Regulatory Platform and Accelerate Global Access to Therapies
GlobeNewswire
·
August 4, 2025
BURLINGAME, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- In a bold move to accelerate regulatory innovation and meet growing global demand, Accumulus Synergy, a nonprofit industry association, today announced the formation of Accumulus Technologies, a new …
TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
GlobeNewswire
·
August 4, 2025
Second quarter 2025 total revenue of $141.1 million, including BRIUMVI U.S. net revenue of $138.8 million Raises full year 2025 BRIUMVI U.S. net revenue target to approximately $570 - $575 million Conference call to be held today, Monday, August 4, 2025, …
Kaspi.kz 2Q & 1H 2025 Financial Results
GlobeNewswire
·
August 4, 2025
ALMATY, Kazakhstan, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) which operates the Kaspi.kz and Kaspi Pay Super Apps in Kazakhstan and owns 66.35% of Hepsiburada in Türkiye, today published its unaudited …
3D Systems Announces Date of Second Quarter 2025 Financial Results
GlobeNewswire
·
August 4, 2025
ROCK HILL, S.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today it will release its financial results for the second quarter 2025 after the U.S. stock markets close on Monday, August 11, 2025. The company will hold a conference …
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
GlobeNewswire
·
August 4, 2025
BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) announced today they have entered into a definitive merger …
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
GlobeNewswire
·
August 4, 2025
BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) announced today they have entered into a definitive merger agreement ( …
BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2025 sowie Informationen zur Geschäftsentwicklung
GlobeNewswire
·
August 4, 2025
BioNTech treibt Onkologiestrategie voran, u.a. mit zwei bekanntgegeben Transaktionen, und setzt damit den Fokus auf die zwei tumorübergreifenden (Pan-Tumor-)Programme: mRNA-Krebsimmuntherapie-Kandidaten und BNT327, ein gegen PD-L11 und VEGF-A gerichteter …
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
GlobeNewswire
·
August 4, 2025
Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific antibody candidate targeting PD-L11 and VEGF-A Entered a …
BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter
GlobeNewswire
·
August 4, 2025
SUNNYVALE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today provides the anticipated timing of regulatory …
Kyrgyz Republic Approved to Proceed with Nano Labs’ CNH-Pegged Stablecoin Initiative
GlobeNewswire
·
August 4, 2025
HONG KONG, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced receipt of approval from the Kyrgyz Republic to proceed …
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2025 of its Virtune Crypto Altcoin Index ETP
GlobeNewswire
·
August 4, 2025
Stockholm, 4th of August 2025 – Virtune AB (Publ) ("Virtune") today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm and Nasdaq Helsinki (ISIN code SE0023260716). In addition to the …
Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för juli 2025 av Virtune Crypto Altcoin Index ETP
GlobeNewswire
·
August 4, 2025
Stockholm, 4 augusti 2025 – Virtune meddelar idag att man har slutfört den månatliga rebalanseringen av Virtune Crypto Altcoin Index ETP, noterad på Nasdaq Stockholm och Nasdaq Helsinki (ISIN-kod SE0023260716). Utöver Virtune Crypto Altcoin Index ETP …
WEEX Burns $2 Million WXT, 0.61% of the Total Supply
GlobeNewswire
·
August 4, 2025
VICTORIA, Seychelles, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WEEX, a leading cryptocurrency exchange successfully completed its second-quarter burn of WEEX Token (WXT), in line with its token burn schedule. The total amount burned was 60,509,555 WXT, …
Microbiotica Announces Completion of Recruitment in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients
GlobeNewswire
·
August 4, 2025
CAMBRIDGE, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is …